Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04269993 · ClinicalTrials.gov registry record · Phase 2
Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis
A Phase 2 study, sponsored by Brown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT04269993 is a Phase 2 study that was terminated before completion, run by Brown University. The registered enrollment target is 3 participants.
The verdict
NCT04269993, a Phase 2 study, was terminated before completion, sponsored by Brown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This laboratory study will investigate the impact of cannabis on pain, affect, and inflammation among patients with rheumatoid or psoriatic arthritis (n = 76). Two cannabis formulations varying in potency will be administered via vaporization across two experimental sessions using a counter-balanced, double-blind, crossover design.
Interventions
- DRUG Cannabis: placebo and medium THC/medium CBD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2023-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04269993
The ClinicalTrials.gov registry entry for NCT04269993 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis: placebo and medium THC/medium CBD is the first listed.
NCT04269993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04269993 about?
NCT04269993 is a clinical study titled "Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis". This laboratory study will investigate the impact of cannabis on pain, affect, and inflammation among patients with rheumatoid or psoriatic arthritis (n = 76). Two cannabis formulations varying in potency will be administered via vaporization across two experimental sessions using a counter-balanced...
What is the current status of trial NCT04269993?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2022-05-18. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04269993?
The interventions under investigation include: Cannabis: placebo and medium THC/medium CBD (DRUG).
Who is sponsoring clinical trial NCT04269993?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.